CordovaCann Corp. (LVRLF)
OTCMKTS · Delayed Price · Currency is USD
0.0498
0.00 (0.00%)
At close: Feb 27, 2026
CordovaCann Revenue
CordovaCann had revenue of 3.45M CAD in the quarter ending December 31, 2025, a decrease of -4.40%. This brings the company's revenue in the last twelve months to 14.05M, down -0.55% year-over-year. In the fiscal year ending June 30, 2025, CordovaCann had annual revenue of 14.25M with 3.28% growth.
Revenue (ttm)
14.05M CAD
Revenue Growth
-0.55%
P/S Ratio
0.53
Revenue / Employee
n/a
Employees
n/a
Market Cap
5.47M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 14.25M | 451.96K | 3.28% |
| Jun 30, 2024 | 13.80M | 202.44K | 1.49% |
| Jun 30, 2023 | 13.59M | 68.62K | 0.51% |
| Jun 30, 2022 | 13.53M | 3.21M | 31.08% |
| Jun 30, 2021 | 10.32M | 10.15M | 6,087.36% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Trees | 14.50M |
| Tristar Wellness Solutions | 4.00M |
| Bio Essence | 565.67K |
| Rafarma Pharmaceuticals | 133.33K |
| Cannabis Bioscience International Holdings | 127.35K |
| Full Alliance Group | 82.12K |